Indication

Deep vein thrombosis prevention

Deep vein thrombosis prevention refers to thromboprophylactic management aimed at inhibiting the development of occlusive thrombi within the deep venous system, most commonly the deep veins of the lower extremities and pelvis. Read more about Deep vein thrombosis prevention

135 drugs 71 manufacturers

Advertisement

Drugs that treat it

Common Deep vein thrombosis prevention therapies.

Showing 28–36 of 135 drugs

WARFARIN SODIUM

ORAL ANTICOAGULANTS·MYOCARDIAL REINFARCTION PREVENTION·+12
TARO PHARM USA
Filter & compare in the drug finder →Opens the drug finder with Deep vein thrombosis prevention preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Deep vein thrombosis prevention.

Deep vein thrombosis prevention refers to thromboprophylactic management aimed at inhibiting the development of occlusive thrombi within the deep venous system, most commonly the deep veins of the lower extremities and pelvis.

This clinical indication is targeted toward at-risk populations, including acutely ill medical inpatients, individuals undergoing major orthopedic or general surgery, and patients experiencing prolonged immobility or hypercoagulable states.

Pathophysiologically driven by Virchow's triad—venous stasis, endothelial injury, and hypercoagulability—uninhibited thrombus generation risks clinical manifestations such as limb pain and edema.

Prophylaxis primarily serves to avert severe sequelae, most critically lethal pulmonary embolism and long-term post-thrombotic syndrome.

Personalize your experience

Follow Deep vein thrombosis prevention and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it